Dermatologic principles and practice in oncology : conditions of the skin, hair, and nails in cancer patients /

"This is the first book to focus on frequent and frequently disabling side effects involving the skin, hair, and nails in cancer patients. It provides detailed descriptions of mechanism-of-action in all current oncology drugs and the clinical presentation and mechanisms underlying their dermato...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Lacouture, Mario E.
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Hoboken, NJ : Wiley-Blackwell, 2013.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Machine generated contents note: Section 1 Dermotology and Oncology 1 Epidemiology and Burden of Disease / Beth McLellan and Mario E. Lacouture
  • 2 The History of Supportive Oncodermatology / Yevgeniy Balagula1, Steven T. Rosen and Mario E. Lacouture
  • 3 Structure and Function of the Integumentary System and the Dermatology Lexicon / Emmy Garber and Amit Garg
  • Types of dermatologic reactions / Raed O. Alhusayen, Sandra R. Knowles and Neil H. Shear
  • 5 Grading Dermatologic Adverse Events on Clinical Trials using CTCAE v4.0 / Alice Chen, Asha Acharya and Ann Setser
  • 6 Psychosocial Issues in Oncology: Clinical management of psychosocial distress, health-related quality of life and special considerations in dermatologic oncology / Lynne I. Wagner and David Cella
  • 7 Dermatopathology / James L. Troy and Molly Hinshaw
  • Section 2 8 Cancer-Related Dermatologic Disorders / Cindy England Owen and Jeffrey P. Callen
  • Section 3 Dermatologic Conditions During Cancer Therapy 9 ORAL MUCOSAL COMPLICATIONS OF CANCER THERAPY / Stephen T. Sonis
  • 10 Hair Disorders Associated with Anticancer Agents / Caroline Yeager and Elise A. Olsen
  • 11 NAIL ABNORMALITIES IN ONCOLOGY PRACTICE / Robert Baran, Bernard Fouilloux and Caroline Robert
  • 12 Pruritus / Tejesh Patel and Gil Yosipovitch
  • 13 Management Options for Hot Flashes in Cancer Patients / Amanda R. Moraska and Charles L. Loprinzi
  • Section 4 Skin toxicities due to chemotherapy 14 Alkylating agents (Busulfan, ThioTEPA, Mechlorethamine, Melphalan, Chlorambucil, cyclophosphamide, ifosfamide, carmustine, streptozocin, dacarbazine, temozolomide, etoposide, BCNU) / Elisabeth Livingstone, Lisa Zimmer, Larissa Schottler, Dirk Schadendorf1
  • 5 Antimetabolite Reactions (Methotrexate, pemetrexed, capecitabine, cytarabine, gemcitabine, 6MP, 6-TG, fludarabine, cladribine) / Emily Y. Chu and Heidi H. Kong
  • 16 Topoisomerase-interacting agents (irinotecan, topotecan, doxorubicin, daunorubicin, epirubicin, idarubicin, mitoxantrone, dactinomycin, etoposide, teniposide) / Tomas Skacel, Roger von Moos and Reinhard Dummer
  • 17 Epidermal Growth Factor Receptor Inhibitor Reactions / Yevgeniy Balagula and Mario E. Lacouture
  • 18 Small Molecule Kinase Inhibitors / Caroline Robert, Vincent Sibaud and Christine Mateus
  • 19 Antimicrotubule agents (Paclitaxel, docetaxel, albumin-bound paclitaxel, vincristine, vinblastine, vi-norelbine, estramustine) / Claus Garbe
  • 20 Histone Deacetylase Inhibitors (HDAC inhibitors) Proteasome inhibitors Demethylating Agents Arsenicals Retinoids / Najla Al-Dawsari, Shannon Campbell and Francine Foss
  • 21 Miscellaneous Reactions (L-Asparaginase, bleomycin, thalidomide, lenalidomide) / Katharina C. Kaehler, Christine B. Boers-Doets, Mario E. Lacouture and Axel Hauschild
  • 22 Skin toxicities due to biotherapy (Interferon-[alpha]2b, Interleukin-2) / Axel Hauschild, Katharina Kaehler and Mario Lacouture
  • 23 Monoclonal antibodies / Caroline Robert
  • 24 Endocrine Agents / Katherine Szyfelbein and Mario Lacouture
  • 25 Agents for the management of hematologic reactions: epotein alpha, darbopoetin, G-CSF, GM-CSF; oprelvekin; low molecular weight heparin; warfarin. / Mee-young Lee and Caroline C. Kim
  • 26 RDERMATOLOGICAL PRINCIPLES AND PRACTICE IN ONCOLOGY / Rebecca Wong and Zahra Kassam
  • 27 Hematopoietic stem cell transplantation and graft-versus-host disease / Stephanie Hu and Jonathan Cotliar
  • 28 Extravasation Reactions / Seppo W. Langer
  • 29 Topical Anticancer Therapies / Patricia L. Myskowski
  • 30 Life-threatening (Serious) Dermatologic Adverse Events / Milan Anadkat
  • 31 Dermatologic infections / Yevgeniy Balagula, Mario E. Lacouture and James I. Ito Section 5
  • 32 Late Dermatologic Conditions / Jennifer Namchoi Section 6 Dermatologic Practice in Oncology 33 Management Algorithms for Dermatologic Adverse Events / Alyx Rosen, Iris Amitay-Laish and Mario E. Lacouture
  • 34 Dermatological therapeutics and formulations / Judy H. Borovicka, Jennifer R.S. Gordon, Ann Cameron Haley and Dennis P. West35 Dermatological Techniques and Procedures / Kishwer Nehal, Erica Lee and Robert Eilers
  • 36 Appearance-Related Concerns in the Cancer Patient / Amy J. Derick.